Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.65 $24.19 Monday, 13th May 2024 PRTA stock ended at $20.71. This is 2.95% less than the trading day before Friday, 10th May 2024. During the day the stock fluctuated 5.72% from a day low at $20.65 to a day high of $21.83.
90 days $19.65 $31.01
52 weeks $19.65 $77.11

Historical Prothena Corporation plc prices

Date Open High Low Close Volume
Mar 01, 2024 $27.86 $28.91 $27.72 $28.53 597 409
Feb 29, 2024 $29.76 $29.76 $27.54 $27.59 667 341
Feb 28, 2024 $29.87 $30.36 $28.91 $28.98 633 907
Feb 27, 2024 $28.87 $31.01 $28.38 $30.30 766 384
Feb 26, 2024 $27.20 $28.43 $27.20 $28.18 522 482
Feb 23, 2024 $27.03 $27.64 $26.80 $27.22 542 257
Feb 22, 2024 $27.00 $27.50 $26.14 $26.95 642 190
Feb 21, 2024 $27.49 $27.86 $26.60 $27.05 579 537
Feb 20, 2024 $27.41 $28.30 $26.89 $27.53 663 799
Feb 16, 2024 $28.45 $30.32 $27.46 $28.02 1 169 607
Feb 15, 2024 $27.23 $28.86 $27.11 $28.52 674 205
Feb 14, 2024 $27.76 $27.76 $25.89 $27.29 732 298
Feb 13, 2024 $27.94 $29.27 $26.35 $26.49 1 064 875
Feb 12, 2024 $28.40 $30.16 $28.40 $29.43 755 983
Feb 09, 2024 $27.65 $28.65 $27.55 $28.38 1 011 866
Feb 08, 2024 $26.55 $27.75 $26.50 $27.43 780 806
Feb 07, 2024 $26.28 $27.13 $25.78 $26.61 573 310
Feb 06, 2024 $25.03 $26.41 $24.60 $26.31 740 541
Feb 05, 2024 $25.27 $25.59 $24.29 $25.05 1 542 725
Feb 02, 2024 $26.92 $27.10 $25.15 $25.77 864 716
Feb 01, 2024 $28.70 $28.79 $27.29 $27.37 805 101
Jan 31, 2024 $29.98 $30.31 $28.27 $28.39 1 237 050
Jan 30, 2024 $31.47 $31.57 $29.40 $29.86 1 286 652
Jan 29, 2024 $32.64 $33.84 $31.72 $33.76 442 853
Jan 26, 2024 $32.43 $33.02 $32.09 $32.63 391 535
Click to get the best stock tips daily for free!

About Prothena Corporation plc

Prothena  plc Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease... PRTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT